Jaume Pons's Insider Trades & SAST Disclosures
Jaume Pons's most recent trade in Alx Oncology Holdings Inc was a trade of 1,326 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Feb. 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jaume Pons.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Jaume Pons | PRESIDENT & CSO | 19 Feb 2025 | 1,326 | 579,388 | - | 1.2 | 1,525 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | PRESIDENT & CSO | 21 Jan 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | PRESIDENT & CSO | 30 Dec 2024 | 10,796 | 580,714 | - | 1.6 | 17,060 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | PRESIDENT & CSO | 14 Aug 2024 | 1,937 | 591,510 | - | 2.6 | 4,997 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 11 Jul 2024 | 20,000 | 613,447 | - | 1.0 | 19,800 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 11 Jul 2024 | 20,000 | 144,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 11 Jul 2024 | 20,000 | 593,447 | - | 7.9 | 158,076 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 01 Jul 2024 | 10,758 | 593,447 | - | 5.8 | 62,599 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 164,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 604,205 | - | 8.4 | 168,652 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 06 May 2024 | 20,000 | 184,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 06 May 2024 | 20,000 | 604,205 | - | 15.9 | 318,334 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 06 May 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 16 Apr 2024 | 50,000 | 604,205 | - | 14.2 | 710,195 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 16 Apr 2024 | 25,846 | 654,205 | - | 1.0 | 25,588 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 16 Apr 2024 | 25,846 | 204,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 04 Apr 2024 | 20,000 | 628,359 | - | 11.2 | 223,036 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 14 Feb 2024 | 30,000 | 648,359 | - | 0 | Common Stock | ||
| Alx Oncology Holdings Inc | Pons Jaume | Director, President & CSO | 29 Dec 2023 | 7,179 | 618,359 | - | 15.0 | 107,972 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 25 Jul 2023 | 282,000 | 282,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 25 Jul 2023 | 89,000 | 625,538 | - | 0 | Common Stock | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 30 Jun 2023 | 3,208 | 536,538 | - | 7.3 | 23,547 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 29 Dec 2022 | 3,232 | 539,746 | - | 11.1 | 35,779 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 05 Aug 2022 | 244,000 | 244,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 05 Aug 2022 | 74,000 | 542,978 | - | 0 | Common Stock | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 03 Feb 2022 | 12,254 | 6,128 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 03 Feb 2022 | 12,254 | 468,978 | - | 1.9 | 23,405 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 03 Feb 2022 | 11,900 | 456,724 | - | 1.0 | 11,781 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 03 Feb 2022 | 11,900 | 230,279 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Oct 2021 | 14,471 | 446,827 | - | 54.2 | 783,848 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Oct 2021 | 14,471 | 446,827 | - | 54.2 | 783,848 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Oct 2021 | 2,229 | 444,598 | - | 55.1 | 122,866 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Oct 2021 | 2,229 | 444,598 | - | 55.1 | 122,866 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 20 Sep 2021 | 10,322 | 463,247 | - | 74.4 | 768,154 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 20 Sep 2021 | 4,429 | 473,569 | - | 73.8 | 326,754 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 20 Sep 2021 | 1,714 | 461,533 | - | 75.5 | 129,336 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 20 Sep 2021 | 235 | 461,298 | - | 76.5 | 17,969 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 30 Jul 2021 | 225,000 | 225,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Jul 2021 | 9,500 | 500,446 | - | 54.4 | 516,553 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Jul 2021 | 5,900 | 494,546 | - | 55.1 | 324,984 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Jul 2021 | 1,300 | 509,946 | - | 53.6 | 69,708 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 21 Jun 2021 | 10,353 | 511,246 | - | 58.9 | 609,976 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 21 Jun 2021 | 6,347 | 521,599 | - | 58.1 | 368,504 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 May 2021 | 15,221 | 528,925 | - | 55.7 | 847,659 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 May 2021 | 979 | 527,946 | - | 56.7 | 55,515 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 May 2021 | 500 | 544,146 | - | 54.2 | 27,102 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Apr 2021 | 6,956 | 549,060 | - | 57.7 | 401,568 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Apr 2021 | 5,330 | 556,016 | - | 56.4 | 300,733 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Apr 2021 | 2,914 | 546,146 | - | 58.4 | 170,054 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Apr 2021 | 837 | 544,646 | - | 60.5 | 50,618 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 19 Apr 2021 | 663 | 545,483 | - | 59.5 | 39,460 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 25 Mar 2021 | 10,000 | 561,346 | - | 1.0 | 9,900 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 25 Mar 2021 | 10,000 | 242,179 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 16,700 | 568,046 | - | 1.9 | 31,897 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 16,700 | 89,019 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 9,200 | 551,946 | - | 69.8 | 641,857 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 2,700 | 561,146 | - | 68.3 | 184,329 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 1,500 | 563,846 | - | 67.2 | 100,773 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 1,200 | 566,846 | - | 63.8 | 76,545 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 900 | 565,946 | - | 65.0 | 58,486 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 600 | 551,346 | - | 70.1 | 42,075 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 22 Mar 2021 | 600 | 565,346 | - | 66.3 | 39,795 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 26 Jan 2021 | 10,000 | 551,346 | - | 1.0 | 9,900 | Common Stock | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, President & CEO | 26 Jan 2021 | 10,000 | 252,179 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 21 Jul 2020 | 27,292 | 541,346 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 21 Jul 2020 | 20,225 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 21 Jul 2020 | 5,264 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President and CEO | 21 Jul 2020 | 1,803 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jaume Pons | Director, President &CEO | 16 Jul 2020 | 272,771 | 272,771 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges